Giant cell tumors (GCTs) are rare osseous tumors that rarely appear in the skull.  We review the clinical course of a 28-year-old previously healthy woman with a complicated GCT.  The reviewed patient presented with a middle cranial fossa tumor acutely complicated by reactive mastoiditis. Left tympanomastoidectomy was performed for drainage of the mastoiditis and for biopsies of the tumor. Due to the challenging tumor location, the patient was treated with denosumab, a fully humanized monoclonal antibody against receptor activator of nuclear factor kappa-B ligand, for 7 months, which resulted in significant preoperative tumor shrinkage. Extensive temporal craniotomy and resection of the tumor followed utilizing a temporomandibular joint total endoprosthesis for reconstruction. A recurrence of the tumor was detected on computed tomography at 19 months after surgery and treated with transtemporal tumor resection, parotidectomy, and mandible re-reconstruction.  A multidisciplinary approach resulted in a good functional result and, finally, an eradication of the challengingly located middle cranial fossa tumor.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045306PMC
http://dx.doi.org/10.1055/s-0036-1592082DOI Listing

Publication Analysis

Top Keywords

tumor
9
multidisciplinary approach
8
middle cranial
8
cranial fossa
8
fossa tumor
8
approach management
4
management temporal
4
temporal bone
4
bone giant
4
giant cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!